MediWound Ltd.
Pharmaceutical company · Yavne, Central District, Israel · Nasdaq: MDWD
MediWound Ltd. is a pharmaceutical company headquartered in Yavne, Central District, Israel. Its shares trade on Nasdaq under the ticker MDWD. The US FDA lists 1 drug manufacturing or testing site registered to the company. It has reported private securities offerings to the US SEC, most recently $17 million sold in a notice filed in 2022.
MediWound at a glance
What does MediWound do?
Operations at its FDA-registered drug sites
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $17.2 million sold (2022).
Where is MediWound located?
Headquarters: Yavne, Central District, Israel
- Yavné, Central DistrictMediWound Ltd · FDA drug site
Frequently asked questions about MediWound
Where is MediWound headquartered?
MediWound Ltd. is headquartered in Yavne, Central District, Israel.
What does MediWound do?
MediWound Ltd. is a pharmaceutical company. Its FDA-registered drug sites are registered for analysis, API manufacturing, labeling and manufacturing. Its SEC industry classification is Medicinal Chemicals & Botanical Products.
Is MediWound a public company?
Yes. MediWound Ltd. trades on Nasdaq under the ticker MDWD.
Similar companies
- UroGen Pharma Ltd.Ra'anana, Central District, Israel
- RedHill Biopharma Ltd.Tel Aviv, Israel
- Chemomab Therapeutics Ltd.Tel Aviv, Israel
- Nasus Pharma LtdTel Aviv, Israel
- Can-Fite BioPharma Ltd.Ramat Gan, Tel Aviv, Israel
- NeuroSense Therapeutics Ltd.Herzliya, Tel Aviv, Israel
- BioLineRx Ltd.Modi‘in Makkabbim Re‘ut, Central District, Israel
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.